LI He,RU Dan,ZHOU Yan,et al.Expert consensus on clinical diagnosis and treatment of myelosuppression in ovarian cancer with integrated Chinese and Western medicine[J].Shanghai Journal of Traditional Chinese Medicine,2024,58(增刊1):22-29.
LI He,RU Dan,ZHOU Yan,et al.Expert consensus on clinical diagnosis and treatment of myelosuppression in ovarian cancer with integrated Chinese and Western medicine[J].Shanghai Journal of Traditional Chinese Medicine,2024,58(增刊1):22-29. DOI: 10.16305/j.1007-1334.2024.05.
Expert consensus on clinical diagnosis and treatment of myelosuppression in ovarian cancer with integrated Chinese and Western medicine
myelosuppression in ovarian cancerShanghai style traditional Chinese medicine gynecologyintegration of traditional Chinese and Western medicineexpert consensus
references
FRIEDRICH M, FRIEDRICH D, KRAFT C, et al. Multimodal treatment of primary advanced ovarian cancer[J]. Anticancer Res, 2021, 41(7): 3253-3260.
CRAWFORD J, DALE D C, LYMAN G H. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management[J]. Cancer, 2004, 100(2): 228-237.
LYMAN G H, ABELLA E, PETTENGELL R. Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review[J]. Crit Rev Oncol Hematol, 2014, 90(3): 190-199.
BLAYNEY D W, SCHWARTZBERG L. Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: A review[J]. Cancer Treat Rev, 2022, 109: 102427.
FORCELLO N P, KHUBCHANDANI S, PATEL S J, et al. Oxaliplatin-induced immune-mediated cytopenias: a case report and literature review[J]. J Oncol Pharm Pract, 2015, 21(2): 148-156.
MACHLUS K R, THON J N, JrITALIANO J E. Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation[J]. Br J Haematol, 2014, 165(2): 227-236.
ZORZI D, LAURENT A, PAWLIK T M, et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases[J]. Br J Surg, 2007, 94(3): 274-286.
ITO K, ITO K. Hematopoietic stem cell fate through metabolic control[J]. Exp Hemato, 2018, 64 : 1-11.
HE M, WANG N, ZHENG W, et al. Ameliorative effects of ginsenosides on myelosuppression induced by chemotherapy or radiotherapy[J]. J Ethnopharmacol, 2021, 268: 113581.
AL-SABAH J, BACCIN C, HAAS S. Single cell and spatial transcript-tomics approaches of the bone marrow microenvironment[J]. Curr Opin Oncol, 2020, 32(2): 146-153.
CRANE G M, JEFFERY E, MORRISON S J. Adult haematopoietic stem cell niches[J]. Nat Rev Immunol, 2017, 17(9): 573-590.
ZHENG P, CHANG X, LU Q, et al. Cytopenia and autoimmune diseases: a vicious cycle fueled by mTOR dysregulation in hematopoietic stem cells[J]. J Autoimmun, 2013, 41: 182-187.
STURGEON C M, DITADI A, AWONG G, et al. Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells[J]. Nat Biotechnol, 2014, 32(6): 554-561.